10 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... staining, NAA (PCR ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... staining, NAA (PCR ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Equina Syndrome Overview ... 33,000-100,000 ppl ... 1.5-3.4 million ppl ... bladder for urinary retention ... axial T1 and T2 Treatment
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
Effusion Lymphoma (PEL ... recommended for KS treatment ... PEL: • Chemotherapy ... #Treatment #management ... infections #HIVAIDS #pharmacology
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
Antibiotics Class Overview ... purposes including PCP ... choice, both for treatment ... #Pharmacology #Antibiotics ... #Review #Overview
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Antibiotics Class Overview ... Strep throat in PCN ... Used for MAC treatment ... #Pharmacology #Antibiotics ... #Review #Overview
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
Recommendations for Prevention ... and Treatment of ... Pneumonia #IDSA #Prevention ... #Treatment #PCP ... HIVAIDS #management #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... prior history of treatment ... Mycobacterium #Tuberculosis ... #TB #IDSA #Prevention ... infections #HIVAIDS #pharmacology
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Antibiotics Class Overview ... so use only if PCN-allergic ... empiric Pseudomonas treatment ... Polymyxin B(IV) #Pharmacology ... Antibiotics #Review #Overview